Elevance beats Q3 profit estimates by 47.8%
Alpha Vantage · AlphaStreet · · AI-summarised by FinFlash
Elevance Health reported third-quarter adjusted earnings of $6.99 per share, beating analyst estimates of $4.73 by 47.8%. Revenue reached $50.44 billion, up 0.7% year over year, with net income of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context